Bright Minds Biosciences (DRUG) Exchange Rate Effect (2020 - 2026)
Bright Minds Biosciences' (DRUG) quarterly Exchange Rate Effect came in at $1.0 million in Q1 2026, up 8938.63% YoY from $11483.2 in Q1 2025, and up 200.82% on a QoQ basis from -$1.0 million in Q4 2025.
Bright Minds Biosciences (DRUG) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Bright Minds Biosciences (DRUG) has 7 years of Exchange Rate Effect data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Exchange Rate Effect rose 8938.63% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$932823.2 (down 177.98% YoY) and the FY2025 annual result came in at $227164.3, up 2544.09% from the prior year.
- Exchange Rate Effect climbed to $1.0 million in Q1 2026, from -$1.0 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.2 million in Q4 2024 to a low of -$1.0 million in Q4 2025.
- A 5-year average of $14624.7 and a median of $3943.3 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2025 — Exchange Rate Effect tumbled 3263.82% — and 2026, when it jumped 8938.63%.
- Tracing DRUG's Exchange Rate Effect over 5 years: stood at $5193.0 in 2022, then plunged by 698.25% to -$31067.2 in 2023, then jumped by 3855.98% to $1.2 million in 2024, then tumbled by 188.23% to -$1.0 million in 2025, then jumped by 200.82% to $1.0 million in 2026.
- The last three Exchange Rate Effect figures came in at $1.0 million (Q1 2026), -$1.0 million (Q4 2025), and -$384416.1 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -14,590.12 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.45 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -287,000.00 |
| 10 | Bright Minds Biosciences | 733.05 Mn | 733.05 Mn | - | 1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.04 Mn |
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Sep 30, 2025 | -384,416.08 |
| Sep 30, 2025 | -384,416.08 |
| Jun 30, 2025 | -556,838.00 |
| Jun 30, 2025 | -556,838.00 |
| Mar 31, 2025 | -11,743.04 |
| Mar 31, 2025 | -11,743.04 |
| Dec 31, 2024 | 1.17 Mn |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 12,150.36 |
| Sep 30, 2024 | 12,150.36 |
| Jun 30, 2024 | 28,956.82 |
| Jun 30, 2024 | 28,956.82 |
| Mar 31, 2024 | -1,606.68 |
| Mar 31, 2024 | -1,606.68 |
| Dec 31, 2023 | -31,067.18 |
| Dec 31, 2023 | -31,067.18 |